Sera Prognostics Profit Margin

Sera Prognostics (SERA) currently reports a profit margin of -47475.71% as of June 2026. That compares with -30306.48% in the prior-year period — down 56.7% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Sera Prognostics's profit margin history and peer comparisons.

Sera Prognostics's profit margin decreased from -30306.48% to -47475.71% — a 56.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sera Prognostics's profit margin of -47475.71% is lower than the Healthcare sector average of 21.34%. That is roughly 222622.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Sera Prognostics's current -47475.71% should be judged against Healthcare norms (sector average: 21.34%) and against SERA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -47475.71%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Sera Prognostics, and consider following SERA for alerts when major investors trade the stock.